Researchers have shown that two lab-developed and nasally-delivered peptides helped slow the spread of alpha-synuclein in mice. 'If these results can be replicated in patients, it would be a remarkable advance in the treatment of devastating neurological disorders,' says the lead author.
from Top Health News -- ScienceDaily https://ift.tt/3zAVugo
Subscribe to:
Post Comments (Atom)
Omicron has cast a shadow of uncertainty on growth outlook: IndiGo CEO
However, the airline is stronger now when compared to situation in 2020 during the first wave of the pandemic, says Ronojoy Dutta from Com...
-
The IT major further said the Ebit margin for the current quarter is expected to be between 20.5-21 per cent from Home Page https://ift.tt...
-
Latest News LIVE updates: Prime Minister Narendra Modi will be on a day's visit to poll-bound Assam and West Bengal on February 7 to lay...
-
Researchers have combined embryonic cells and liver cells in a new cell culture test. This combination lets them detect adverse effects that...
No comments:
Post a Comment